Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Ragnar Befrits"'
Autor:
Hiwa K. Saaed, Lisa Chiggiato, Dominic-Luc Webb, Ann-Sofie Rehnberg, Carlos A. Rubio, Ragnar Befrits, Per M. Hellström
Publikováno v:
Upsala Journal of Medical Sciences, Vol 126, Pp 1-9 (2021)
Background: Gastric nitric oxide (NO) production in response to Helicobacter pylori via inducible nitric oxide synthase (iNOS) is suggested as a biomarker of inflammation and cytotoxicity. The aim of this study was to investigate relationships betwee
Externí odkaz:
https://doaj.org/article/69c340234e45456ba22a6df66e9f2363
Autor:
Peter Benno MD, PhD, Atti-La Dahlgren MD, Ragnar Befrits MD, PhD, Elisabeth Norin PhD, Per M. Hellström MD, PhD, Tore Midtvedt MD, PhD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 4 (2016)
Irritable bowel syndrome is a chronic gastrointestinal disorder characterized by abdominal pain and altered bowel habits in the absence of organic disease. We present 2 cases where diarrhea-predominant irritable bowel syndrome occurred in association
Externí odkaz:
https://doaj.org/article/080fcee91373466d892ec8bbef5b7eb6
Autor:
Francesca Anedda, Marco Zucchelli, Danika Schepis, Anna Hellquist, Lucia Corrado, Sandra D'Alfonso, Adnane Achour, Gerald McInerney, Alejandro Bertorello, Mikael Lördal, Ragnar Befrits, Jan Björk, Francesca Bresso, Leif Törkvist, Jonas Halfvarson, Juha Kere, Mauro D'Amato
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e29523 (2011)
BACKGROUND: neuropeptide S (NPS) and its receptor NPSR1 act along the hypothalamic-pituitary-adrenal axis to modulate anxiety, fear responses, nociception and inflammation. The importance of the NPS-NPSR1 signaling pathway is highlighted by the obser
Externí odkaz:
https://doaj.org/article/e21b1526af734421a6616a78b91a66e1
Autor:
Ragnar Befrits, Annika Olsson, Soo Aleman, Akter Hossain, Mikael Lördal, Anette Storlåhls, Michael Eberhardson
Publikováno v:
Scandinavian Journal of Gastroenterology. 55:178-183
Objectives: Anti-TNF treatment is established for patients with severe inflammatory bowel disease (IBD) refractory to conventional medication. However, long-term real-life observations are limited....
Autor:
Per M. Hellström, Ragnar Befrits, Dominic-Luc Webb, Lisa Chiggiato, Carlos A. Rubio, Ann-Sofie Rehnberg, Hiwa Saaed
Publikováno v:
Gastroenterology. 160:S-464
Autor:
Annelie Lindberg, Olle Broström, Lena Oxelmark, Ragnar Befrits, Bjöörn Fossum, Curt Tysk, Sven Almer, Robert Löfberg, Berit Sternby, Per Karlén, Anders Eriksson
Publikováno v:
European Journal of Gastroenterology & Hepatology
Background There is an increasing interest in complementary and alternative medicine (CAM) in patients with chronic diseases, including those with inflammatory bowel disease (IBD). Patients may turn to CAM when conventional therapies are inadequate o
Autor:
Tryggve Ljung, Per M. Hellström, Maria Lönnkvist, Hetzel Diaz-Tartera, Mikael Holst, Ragnar Befrits, Johanna Engström
Background: Fecal calprotectin (FC) and serum C-reactive protein (CRP) are biomarkers of disease activity in Crohn's disease (CD) and ulcerative colitis (UC). We assessed FC, CRP, Harvey-Bradshaw index (HBi), partial Mayo Clinic Scoring (pMCS) and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::677197bc66cfa79a1fd0928530392b18
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396104
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396104
Autor:
Ragnar Befrits, Hans Hildebrand, Johan Lindholm, Scott Montgomery, Petter Malmborg, Lena Grahnquist, Jan Björk, Maja Ideström
Publikováno v:
Inflammatory Bowel Diseases. 21:1098-1108
Background Some studies have suggested that childhood-onset inflammatory bowel disease (IBD) is characterized by extensive intestinal involvement and rapid progression to complications. Here, we report the presentation and progression of patients dia
Autor:
Ulf Sundin, Laura Landucci, Loa Davidsdottir, Ann-Charlotte Wikström, Ragnar Befrits, Michael Eberhardson, Per Marits, Jakob Nilsson
Publikováno v:
Journal of Crohn's and Colitis. 8:881-889
The anti-TNF antibody infliximab is effective in inducing remission in Crohn's disease as well as in ulcerative colitis and many patients are treated for several years with sustained clinical remission. However, the role of monitoring s-infliximab an
Autor:
Christoph Gasche, Fernando Magro, Jürgen Stein, Silvio Danese, Maja Gudehus, Eric Lerebours, Fermín Mearin, Bas Oldenburg, Daniell Mitchell, Ragnar Befrits, Palle Bager
Publikováno v:
Stein, J, Bager, P, Befrits, R, Gasche, C, Gudehus, M, Lerebours, E, Magro, F, Mearin, F, Mitchell, D, Oldenburg, B & Danese, S 2013, ' Anaemia management in patients with inflammatory bowel disease : routine practice across nine European countries ', European Journal of Gastroenterology and Hepatology, vol. 25, no. 12, pp. 1456-63 . https://doi.org/10.1097/MEG.0b013e328365ca7f
Anaemia and iron deficiency (ID) are common complications in inflammatory bowel disease (IBD). In patients undergoing iron therapy, intravenous iron supplementation is recommended in preference to oral therapy. This study evaluated routine practice i